Published on New York State Department of Health, Wadsworth Center (https://wadsworth.org)

Esoterix Inc

Project ID
35769
Facility Name
Esoterix Inc
Analyte
Infliximab (IFX) drug level quantitative measurement
Method
electrochemiluminescent immunoassay on Mesoscale Discovery (MSD) platform
Specimen Type
serum
Permit Category
Ther. Sub. Mon./Quant. Tox.
Status
Approved
Facility State
CA
Facility ID
3072